Ascendis Pharma

AstraZeneca’s hat-trick, a broad sell-off and Alzinova funds its Alzheimer’s push – the Nordic Pulse | 2026:37

AstraZeneca strikes again, BioArctic’s Leqembi goes global and Cinclus holds its breath – the Nordic Pulse | 2026:36

BioArctic’s home-run, a third win for Astra’s Tezspire and a path to phase III for Lytix – the Nordic Pulse | 2026:35

Demant raises the bar, XVIVO clears hearts and Zealand cashes in – the Nordic Pulse | 2026:33

Novo raises outlook, BioInvent breaks through, Nordics tread water – the Nordic Pulse | 2026:32

Hansa closes, AlzeCure soars, Ascelia falters – the Nordic Pulse | 2026:27

BioArctic lands Lilly, Sobi takes a late hit – the Nordic Pulse | 2026:26

Ascendis Pharma rapporterar långsiktiga positiva resultat för behandling av hypoparatyreoidism

Ascendis Pharma lämnar in marknadsansökan till EMA

Nyhetssvepet tisdag 16 november

Coegin Pharma

Nyhetssvepet fredag 30 augusti

Ett redaktionellt urval av dagens Life Science-nyheter